Hisou-Chi Liou, Ph.D., CFA

Hsiou-Chi Liou, Ph.D., CFA

Head, Corporate Development and Strategy

  • Director of Finance, APRINOIA Therapeutics
  • Portfolio Advisor, Bank of America Merrill Lynch
  • Equity Analyst, Biovantage Investments
  • Co-founder, ImmuneTarget
  • Faculty, Weill Cornell Medical College
  • Postdoctoral fellow, MIT and Rockefeller University
  • PhD, Harvard School of Public Health
  • MS in Cytogenetics, National Taiwan University
  • Drug discovery in immunological diseases and oncology, transcriptional regulation, financial modeling, asset valuation, portfolio management, risk management